Short-term oral corticosteroid use and risk for major adverse cardiovascular events within one year in patients with chronic obstructive pulmonary disease, a Danish registry-based cohort study

Background Exacerbations of chronic obstructive pulmonary disease (COPD) often require treatment with oral corticosteroids (OCS). While OCS can improve forced expiratory volume in first second (FEV1) in the short term, there are still concerns about their potential cardiovascular adverse effects. Ev...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Gertrud Baunsgaard-Pedersen, Barbara Bonnesen, Josefin Eklöf, Jens Ulrik Stæhr Jensen, Pradeesh Sivapalan
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Taylor & Francis Group 2026-12-01
Ráidu:	European Clinical Respiratory Journal
Fáttát:	Chronic obstructive pulmonary disease oral corticosteroids antibiotics for respiratory infections major adverse cardiovascular events cohort study propensity score matching
Liŋkkat:	https://www.tandfonline.com/doi/10.1080/20018525.2026.2616846
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!